. 2019 Dec 12;19(8):1–108.

Table 8:

Time in Target Glucose Range and Hypoglycemia and Glucose Variability for People With Type 2 Diabetes

Group Means				Difference Between Flash and SMBG (% Change)	Difference in End-of-Study Adjusted Means Between Flash and SMBG (95% CI)	P Value
Flash		SMBG
Baseline	Study End	Baseline	Study End
Hours in target glucose range (3.9–10.0 mmol/L) within 24 hours
13.9	13.6	13.5	13.2	1.1%	0.2 (−0.94, 1.34)	.7925
Hours above target glucose range (> 13.3 mmol/L) within 24 hours
3.1	3.5	3.9	3.9	2.1%	0.1 (−0.80 to 1.00)	.8729
Hours in hypoglycemia (< 3.9 mmol/L) within 24 hours
1.3	0.59	3.44	3.27	−38.0%	−1.24 (−1.71 to −0.77)	< .0001
Hours in hypoglycemia at night (11 pm-6 am) within 7 hours
0.55	0.23	0.49	0.51	−54.3%	−0.29 (−0.45, −0.13)	.0001
Mean hypoglycemia events < 3.9 mmol/L (70 mg/dL) within 24 hours
0.64	0.38	0.63	0.53	27.7%	−0.16 (−0.29 to −0.03)	.0164
Hours in hyperglycemia (> 13.3 mmol/L) within 24 hours
3.1	3.5	3.9	3.9	2.1%	0.1 (−0.80, 1.00)	.8729
Mean amplitude of glucose excursion^a
128	125	131	131	NA	−4.0 (−10.47 to −2.47)	.1909
Blood glucose risk index^a
9.5	9.9	10.4	10.5	NA	0.0 (−1.37 to 1.37)	.9431
Coefficient of variation in glucose, %^a
34.1	31.4	33.1	33.0	NA	−2.26 (−3.65 to −0.868)	.0017
Low blood glucose risk index^a
1.1	0.60	1.0	0.90	NA	−0.30 (−0.52 to −0.08)	.0029
Standard deviation of glucose, mg/dL^a
56	54	56	56	NA	−1.67 (−4.51 to −1.17)	.2538
Continuous overall net glycemic action, 2 hours, mg/dL^a
49	47	50	51	NA	−3.0 (−5.55 to −0.45)	.0385
Continuous overall net glycemic action, 4 hours, mg/dL^a
61	57	61	64	NA	−5.0 (−9.31 to −0.69)	.0133
Continuous overall net glycemic action, 6 hours, mg/dL^a
63	58	62	65	NA	−8.0 (−13.88 to −2.12)	.0046

Abbreviations: CI, confidence interval; NA, not applicable; SMBG, self-monitoring of blood glucose.

A scale for measuring glucose variability.

Source: Haak et al.³³